Literature DB >> 33456613

Development of a Knowledge-based Clinical Decision Support System for Multiple Sclerosis Diagnosis.

Azamossadat Hosseini1, Farkhondeh Asadi1, Leila Akramian Arani1.   

Abstract

The diagnosis of multiple sclerosis (MS) is difficult considering its complexity, variety in signs and symptoms, and its similarity to the signs and symptoms of other neurological diseases. The purpose of this study is to design and develop a clinical decision support system (CDSS) to help physicians diagnose MS with a relapsing-remitting phenotype. The CDSS software was developed in four stages: requirement analysis, system design, system development, and system evaluation. The Rational Rose and SQL Server were used to design the object-oriented conceptual model and develop the database. The C sharp programming language and the Visual Studio programming environment were used to develop the software. To evaluate the efficiency and applicability of the software, the data of 130 medical records of patients aged 20 to 40 between 2017 and 2019 were used along with the Nilsson standard questionnaire. SPSS Statistics was also used to analyze the data. For MS diagnosis, CDSS had a sensitivity, specificity and accuracy of 1, 0.97 and 0.99, respectively, and the area under the ROC curve was 0.98. The agreement rate of kappa coefficient (κ) between software diagnosis and physician's diagnosis was 0.98. The average score of software users was 98.33%, 96.65%, and 96.9% regarding the ease of learning, memorability, and satisfaction, respectively. Therefore, the applicability of the CDSS for MS diagnosis was confirmed by the neurologists. The evaluation findings show that CDSS can help physicians in the accurate and timely diagnosis of MS by using the rule-based method. ©Carol Davila University Press.

Entities:  

Keywords:  Clinical; decision support system; diagnosis; multiple sclerosis

Year:  2020        PMID: 33456613      PMCID: PMC7803311          DOI: 10.25122/jml-2020-0182

Source DB:  PubMed          Journal:  J Med Life        ISSN: 1844-122X


  12 in total

Review 1.  The differential diagnosis of multiple sclerosis.

Authors:  N Scolding
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-12       Impact factor: 10.154

2.  Multiple sclerosis- diagnosis, management and prognosis.

Authors:  Benjamin K-T Tsang; Richard Macdonell
Journal:  Aust Fam Physician       Date:  2011-12

Review 3.  Evolution of diagnostic criteria for multiple sclerosis.

Authors:  Joanna Przybek; Inga Gniatkowska; Dagmara Mirowska-Guzel; Anna Członkowska
Journal:  Neurol Neurochir Pol       Date:  2015-08-05       Impact factor: 1.621

Review 4.  The differential diagnosis of multiple sclerosis.

Authors:  Loren A Rolak; John O Fleming
Journal:  Neurologist       Date:  2007-03       Impact factor: 1.398

Review 5.  The importance of early diagnosis of multiple sclerosis.

Authors:  James R Miller
Journal:  J Manag Care Pharm       Date:  2004-06

Review 6.  Diagnostic modalities in multiple sclerosis: perspectives in children.

Authors:  I-Jun Chou; William P Whitehouse; Huei-Shyong Wang; Radu Tanasescu; Cris S Constantinescu
Journal:  Biomed J       Date:  2014 Mar-Apr       Impact factor: 4.910

7.  "Undiagnosing" multiple sclerosis: the challenge of misdiagnosis in MS.

Authors:  Andrew J Solomon; Eran P Klein; Dennis Bourdette
Journal:  Neurology       Date:  2012-05-11       Impact factor: 9.910

8.  Patterns of misdiagnosis of multiple sclerosis.

Authors:  Netta Levin; Michal Mor; Tamir Ben-Hur
Journal:  Isr Med Assoc J       Date:  2003-07       Impact factor: 0.892

9.  Determining Multiple Sclerosis Phenotype from Electronic Medical Records.

Authors:  Richard E Nelson; Jorie Butler; Joanne LaFleur; Kristin Knippenberg; Aaron W C Kamauu; Scott L DuVall
Journal:  J Manag Care Spec Pharm       Date:  2016-12

10.  Fabry disease - underestimated in the differential diagnosis of multiple sclerosis?

Authors:  Tobias Böttcher; Arndt Rolfs; Christian Tanislav; Andreas Bitsch; Wolfgang Köhler; Jens Gaedeke; Anne-Katrin Giese; Edwin H Kolodny; Thomas Duning
Journal:  PLoS One       Date:  2013-08-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.